POTOMAC, Md. – August 31, 2026 – IGC Pharma, Inc. (NYSE: IGC) is gaining attention after Ascendiant Capital Markets raised its 12-month price target to $6.00 from $5.50 while maintaining…
SAN DIEGO, Calif., August 26, 2026 — Drug discovery can begin with 5,000 to 10,000 compounds, narrow to approximately 250 entering preclinical development, around five reaching clinical trials and ultimately…
Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) is expanding its commercial graphene portfolio into the rapidly growing AI data center cooling and high-density computing infrastructure market with the launch…
August 20, 2026 — VivoSim Labs, Inc. (NASDAQ: VIVS) is drawing investor attention following an initiation-of-coverage research report highlighting the company’s NAMkind™ 3D human tissue models, AI-powered toxicology analytics, early…
Aug. 20, 2026 Peraso Inc. (NASDAQ: PRSO) is emerging as a potential micro-cap turnaround story as the 60GHz millimeter-wave (mmWave) semiconductor company expands beyond its legacy fixed wireless access business…
Aug. 19, 2026 — Micro-cap stocks across biotechnology, neurodegenerative disease, quantum computing and artificial intelligence are drawing investor attention as fresh corporate developments create potential catalysts. IGC Pharma, Inc. (NYSE:…
** Aug. 19, 2026** Investors looking across both U.S. and Canadian markets are watching a group of dual-listed companies spanning graphene technology, infrastructure, gold mining, critical materials and energy storage.…
Aug. 18, 2026 – Sphere 3D Corp. (NASDAQ: ANY) is moving deeper into artificial intelligence, high-performance computing (HPC) and data center infrastructure, outlining a development strategy built around energized power,…
Aug. 18, 2026 — Peraso Inc. (NASDAQ: PRSO) is gaining renewed investor attention after Ladenburg Thalmann maintained its Buy rating and raised its 12-month price target to $3.25 from $2.75,…
August 17, 2026 — VivoSim Labs, Inc. (NASDAQ: VIVS) is gaining investor attention as its 3D human tissue models, artificial intelligence and New Approach Methodologies (NAMs) target one of pharmaceutical…
